RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/22087027http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/22087027http://www.w3.org/2000/01/rdf-schema#comment"Myostatin inhibition by follistatin (FS) offers a new approach for muscle mass enhancement. The aim of the present study was to characterize the mediators responsible for the FS hypertrophic action on skeletal muscle in male mice. Because IGF-I and IGF-II, two crucial skeletal muscle growth factors, are induced by myostatin inhibition, we assessed their role in FS action. First, we tested whether type 1 IGF receptor (IGF-IR) is required for FS-induced hypertrophy. By using mice expressing a dominant-negative IGF-IR in skeletal muscle, we showed that IGF-IR inhibition blunted by 63% fiber hypertrophy caused by FS. Second, we showed that FS caused the same degree of fiber hypertrophy in wild-type and IGF-II knockout mice. We then tested the role of the signaling molecules stimulated by IGF-IR, in particular the Akt/mammalian target of rapamycin (mTOR)/70-kDa ribosomal protein S6 kinase (S6K) pathway. We investigated whether Akt phosphorylation is required for the FS action. By cotransfecting a dominant-negative form of Akt together with FS, we showed that Akt inhibition reduced by 65% fiber hypertrophy caused by FS. Second, we evaluated the role of mTOR in FS action. Fiber hypertrophy induced by FS was reduced by 36% in rapamycin-treated mice. Finally, because the activity of S6K is increased by FS, we tested its role in FS action. FS caused the same degree of fiber hypertrophy in wild-type and S6K1/2 knockout mice. In conclusion, the IGF-IR/Akt/mTOR pathway plays a critical role in FS-induced muscle hypertrophy. In contrast, induction of IGF-II expression and S6K activity by FS are not required for the hypertrophic action of FS."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.org/dc/terms/identifier"doi:10.1210/en.2011-1687"xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/author"Bertrand L."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/author"Pende M."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/author"Lause P."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/author"Thissen J.P."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/author"Gilson H."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/author"Schakman O."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/author"Kalista S."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/author"Demeulder B."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/name"Endocrinology"xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/pages"241-253"xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/title"The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy."xsd:string
http://purl.uniprot.org/citations/22087027http://purl.uniprot.org/core/volume"153"xsd:string
http://purl.uniprot.org/citations/22087027http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/22087027
http://purl.uniprot.org/citations/22087027http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/22087027
http://purl.uniprot.org/uniprot/#_D3YWB8-mappedCitation-22087027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22087027
http://purl.uniprot.org/uniprot/#_A0A494BBF8-mappedCitation-22087027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22087027
http://purl.uniprot.org/uniprot/#_A0A494BA73-mappedCitation-22087027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22087027
http://purl.uniprot.org/uniprot/#_E9QNX9-mappedCitation-22087027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22087027
http://purl.uniprot.org/uniprot/#_B0LAD8-mappedCitation-22087027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22087027
http://purl.uniprot.org/uniprot/#_D3Z4N4-mappedCitation-22087027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22087027
http://purl.uniprot.org/uniprot/#_D6RH86-mappedCitation-22087027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22087027